Very-high-risk (VHR) localized prostate cancer: an indication for multimodal therapy
Oncotarget
.
2019 Mar 8;10(20):1870-1871.
doi: 10.18632/oncotarget.26757.
Authors
Debasish Sundi
1
,
Brian F Chapin
2
Affiliations
1
Department of Urology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
2
Department of Urology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
PMID:
30956769
PMCID:
PMC6443009
DOI:
10.18632/oncotarget.26757
No abstract available
Keywords:
metastasis; prostate cancer; risk stratification; survival.
Publication types
Editorial